세계의 의료용 바이오미메틱스 시장 보고서(2025년)

Medical biomimetics refers to the development and application of innovative technologies that replicate and enhance natural physiological processes, aiming to create functional and biomechanically optimized solutions in the field of healthcare. Medical biomimetics plays a crucial role in advancing the field of artificial organs and tissues. It is extensively employed in the design of drug delivery systems that emulate biological processes, improving the precision and efficiency of targeted medication delivery.

The main types of medical biomimetics are cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the study and application of principles inspired by nature to develop innovative solutions for heart and vascular-related medical challenges. These are used in various applications such as wound healing, tissue engineering, drug delivery, and others and are used by various end-users such as hospitals, specialty clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The main types of medical biomimetics are cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the study and application of principles inspired by nature to develop innovative solutions for heart and vascular-related medical challenges. These are used in various applications such as wound healing, tissue engineering, drug delivery, and others and are used by various end-users such as hospitals, specialty clinics, and others.

The medical biomimetics market size has grown strongly in recent years. It will grow from $36.6 billion in 2024 to $39.44 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increased biomimetic materials, increased research funding, aging population, rising chronic diseases.

The medical biomimetics market size is expected to see strong growth in the next few years. It will grow to $50.4 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing demand for organ transplants, growing awareness of biomimetics applications, rising healthcare expenditure, expanding biotechnology sector, advancements in tissue engineering. Major trends in the forecast period include Bio-inspired prosthetics, biomimetic sensors, synthetic biology applications, smart drug delivery systems, biologically inspired robotics, Personalized medicine, 3D printing technologies, artificial intelligence in diagnostics, nanotechnology applications, regenerative medicine.

The forecast of 6.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. research and development (R&D) by driving up the cost of bioengineered tissue scaffolds and synthetic vascular grafts sourced from Sweden and Singapore, delaying regenerative therapies and increasing biotech development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of obesity and heart disease is expected to drive the growth of the medical biomimetics market. Obesity is a condition in which excess body fat accumulates to unhealthy levels, while heart disease encompasses a variety of conditions that affect the heart and blood vessels. Biomimetics plays a crucial role in developing assistive devices, such as orthotics and prosthetics, that can help individuals with conditions like diabetes or obesity manage their health. For example, in August 2022, a report by the American College of Cardiology, a US-based non-profit medical association, projected an increase in all four major cardiovascular risk factors in the United States from 2025 to 2060. The largest rise was anticipated in diabetes, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). The study also indicated significant increases in cardiovascular disease rates, particularly for stroke (33.8% to 15 million), heart failure (33.4% to 13 million), ischemic heart disease (30.7% to 29 million), and heart attack (16.9% to 16 million). As a result, the growing rates of obesity and heart disease are contributing to the expansion of the medical biomimetics market.

Major companies operating in the medical biomimetics market are focused on developing innovative products with advanced technologies, such as suture anchor system to increase their profitability in market. A suture anchor system is a medical device used in orthopedic and sports medicine procedures for securing soft tissues, such as tendons or ligaments, to bone. Suture anchor systems strive to replicate and improve upon the natural attachment of soft tissues to bone, offering a functional and biomechanically optimized solution mirroring physiological tissue connections in the human body. For instance, in December 2022, Stryker Corporation, a US-based multinational medical technologies company, launches Citrefix, a disposable suture anchor system, incorporates a resorbable biomimetic anchor body using Citregen, an elastomeric material crafted from a citrate polymer, specifically engineered to emulate bone chemistry. This design allows for controlled resorption without inducing chronic inflammation. It is a disposable suture anchor system that is designed to help grafted tissue heal and healthy bone grow when used in orthopedic surgical applications.

In July 2024, Edwards Lifesciences, a US-based medical technology company, acquired Innovalve Bio Medical for $300 million. This acquisition allows Edwards to reinforce its position in the expanding market for TMVR devices, which is expected to experience significant growth in the coming years. Innovalve Bio Medical is an Israel-based provider of medical biomimetics.

Major companies operating in the medical biomimetics market are BASF SE, Bayer Aktiengesellschaft, Abbott Laboratories, Stryker Corporation, Zimmer Biomet Holdings Inc., Otsuka Medical Device Company Ltd., LivaNova PLC, Ossur hf., Forschungszentrum Julich GmbH, Biohorizons Implant Systems Inc., Inventia Plc, Blatchford Limited, Keystone Dental Corporation, Xtant Medical Holdings Inc., AVINENT Science and Technology, SynTouch Inc., Curasan Inc., CorNeat Vision Inc., Hstar Technologies Co. Ltd., Veryan Medical Ltd., Swedish Biomimetics 3000 ApS, Osteopore International Pte Ltd., KitoTech Medical Ltd., Vandstrom Inc.

North America was the largest region in the medical biomimetics market in 2024. The regions covered in the medical biomimetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical biomimetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical biomimetics market consists of sales of diagnostic tools, wound healing products, bio-inspired robotics, bioelectronic devices and regenerative medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Biomimetics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical biomimetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical biomimetics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical biomimetics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Cardiovascular; Orthopedic; Ophthalmology; Dental; Other Types
• 2) By Application: Wound Healing; Tissue Engineering; Drug Delivery; Other Applications
• 3) By End User: Hospitals; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Cardiovascular: Vascular Grafts; Stents and Heart Valves; Cardiac Assist Devices
• 2) By Orthopedic: Bone Grafts; Joint Replacement Implants; Spinal Implants
• 3) By Ophthalmology: Artificial Corneas; Retinal Implants; Intraocular Lenses
• 4) By Dental: Dental Implants; Bone Regeneration Products; Biocompatible Materials
• 5) By Other Types: Wound Healing Products; Tissue Engineering Scaffolds; Neurological Devices
• Companies Mentioned: BASF SE; Bayer Aktiengesellschaft; Abbott Laboratories; Stryker Corporation; Zimmer Biomet Holdings Inc.; Otsuka Medical Device Company Ltd.; LivaNova PLC; Ossur hf.; Forschungszentrum Julich GmbH; Biohorizons Implant Systems Inc.; Inventia Plc; Blatchford Limited; Keystone Dental Corporation; Xtant Medical Holdings Inc.; AVINENT Science and Technology; SynTouch Inc.; Curasan Inc.; CorNeat Vision Inc.; Hstar Technologies Co. Ltd.; Veryan Medical Ltd.; Swedish Biomimetics 3000 ApS; Osteopore International Pte Ltd.; KitoTech Medical Ltd.; Vandstrom Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Biomimetics Market Characteristics

3. Medical Biomimetics Market Trends And Strategies

4. Medical Biomimetics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Medical Biomimetics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Medical Biomimetics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Medical Biomimetics Market Growth Rate Analysis
• 5.4. Global Medical Biomimetics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Medical Biomimetics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Medical Biomimetics Total Addressable Market (TAM)

6. Medical Biomimetics Market Segmentation

• 6.1. Global Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular
• Orthopedic
• Ophthalmology
• Dental
• Other Types
• 6.2. Global Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wound Healing
• Tissue Engineering
• Drug Delivery
• Other Applications
• 6.3. Global Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Other End Users
• 6.4. Global Medical Biomimetics Market, Sub-Segmentation Of Cardiovascular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vascular Grafts
• Stents and Heart Valves
• Cardiac Assist Devices
• 6.5. Global Medical Biomimetics Market, Sub-Segmentation Of Orthopedic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone Grafts
• Joint Replacement Implants
• Spinal Implants
• 6.6. Global Medical Biomimetics Market, Sub-Segmentation Of Ophthalmology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Artificial Corneas
• Retinal Implants
• Intraocular Lenses
• 6.7. Global Medical Biomimetics Market, Sub-Segmentation Of Dental, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dental Implants
• Bone Regeneration Products
• Biocompatible Materials
• 6.8. Global Medical Biomimetics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wound Healing Products
• Tissue Engineering Scaffolds
• Neurological Devices

7. Medical Biomimetics Market Regional And Country Analysis

• 7.1. Global Medical Biomimetics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Medical Biomimetics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Medical Biomimetics Market

• 8.1. Asia-Pacific Medical Biomimetics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Medical Biomimetics Market

• 9.1. China Medical Biomimetics Market Overview
• 9.2. China Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Medical Biomimetics Market

• 10.1. India Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Medical Biomimetics Market

• 11.1. Japan Medical Biomimetics Market Overview
• 11.2. Japan Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Medical Biomimetics Market

• 12.1. Australia Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Medical Biomimetics Market

• 13.1. Indonesia Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Medical Biomimetics Market

• 14.1. South Korea Medical Biomimetics Market Overview
• 14.2. South Korea Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Medical Biomimetics Market

• 15.1. Western Europe Medical Biomimetics Market Overview
• 15.2. Western Europe Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Medical Biomimetics Market

• 16.1. UK Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Medical Biomimetics Market

• 17.1. Germany Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Medical Biomimetics Market

• 18.1. France Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Medical Biomimetics Market

• 19.1. Italy Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Medical Biomimetics Market

• 20.1. Spain Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Medical Biomimetics Market

• 21.1. Eastern Europe Medical Biomimetics Market Overview
• 21.2. Eastern Europe Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Medical Biomimetics Market

• 22.1. Russia Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Medical Biomimetics Market

• 23.1. North America Medical Biomimetics Market Overview
• 23.2. North America Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Medical Biomimetics Market

• 24.1. USA Medical Biomimetics Market Overview
• 24.2. USA Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Medical Biomimetics Market

• 25.1. Canada Medical Biomimetics Market Overview
• 25.2. Canada Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Medical Biomimetics Market

• 26.1. South America Medical Biomimetics Market Overview
• 26.2. South America Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Medical Biomimetics Market

• 27.1. Brazil Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Medical Biomimetics Market

• 28.1. Middle East Medical Biomimetics Market Overview
• 28.2. Middle East Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Medical Biomimetics Market

• 29.1. Africa Medical Biomimetics Market Overview
• 29.2. Africa Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Medical Biomimetics Market Competitive Landscape And Company Profiles

• 30.1. Medical Biomimetics Market Competitive Landscape
• 30.2. Medical Biomimetics Market Company Profiles
  • 30.2.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Medical Biomimetics Market Other Major And Innovative Companies

• 31.1. Otsuka Medical Device Company Ltd.
• 31.2. LivaNova PLC
• 31.3. Ossur hf.
• 31.4. Forschungszentrum Julich GmbH
• 31.5. Biohorizons Implant Systems Inc.
• 31.6. Inventia Plc
• 31.7. Blatchford Limited
• 31.8. Keystone Dental Corporation
• 31.9. Xtant Medical Holdings Inc.
• 31.10. AVINENT Science and Technology
• 31.11. SynTouch Inc.
• 31.12. Curasan Inc.
• 31.13. CorNeat Vision Inc.
• 31.14. Hstar Technologies Co. Ltd.
• 31.15. Veryan Medical Ltd.

32. Global Medical Biomimetics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Biomimetics Market

34. Recent Developments In The Medical Biomimetics Market

35. Medical Biomimetics Market High Potential Countries, Segments and Strategies

• 35.1 Medical Biomimetics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Medical Biomimetics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Medical Biomimetics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer